Octreotide acetate microspheres (CSPC Pharmaceutical Group)

醋酸奥曲肽微球 (石药集团)

Report date: 2025/05/29 15:39:54

Base Information

Drug NameOctreotide acetate microspheres (CSPC Pharmaceutical Group)
Drug Alias NameSYHX-2008
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGrowth hormone releasing factor antagonistsSomatostatin receptor agonists
TargetsGrowth hormone releasing factorSomatostatin receptor
Therapy Area/IndicationsPancreatic neuroendocrine tumors (pNET)Acromegaly
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesCSPC Pharmaceutical Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic neuroendocrine tumors (pNET)Acromegaly
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A